NBIX Return on Tangible Equity | NEUROCRINE BIOSCIENCES INC

NEUROCRINE BIOSCIENCES INC (NBIX) Return on Tangible Equity

2026-06-30: Return Tang Equity 72.96%.
2026-03-31: Return Tang Equity 19.68%.
2025-12-31: Return Tang Equity 14.76%.
2025-09-30: Return Tang Equity 14.28%.

Complete source-backed return tang equity history.

Available history: 2009-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	72.96%
2026-03-31	19.68%
2025-12-31	14.76%
2025-09-30	14.28%
2025-06-30	12.95%
2025-03-31	12.09%
2024-12-31	13.21%
2024-09-30	14.23%
2024-06-30	13.55%
2024-03-31	15.53%
2023-12-31	11.22%
2023-09-30	9.57%
2023-06-30	9.55%
2023-03-31	3.81%
2022-12-31	9.08%
2022-09-30	3.77%
2022-06-30	0.86%
2022-03-31	5.13%
2021-12-31	6.52%
2021-09-30	33.05%
2021-06-30	28.51%
2021-03-31	33.34%
2020-12-31	36.17%
2020-09-30	11.61%
2020-06-30	24.64%
2020-03-31	25.20%
2019-12-31	5.81%
2019-09-30	3.67%
2019-06-30	3.73%
2019-03-31	-9.57%
2018-12-31	4.39%
2018-09-30	2.22%
2018-06-30	-13.77%
2018-03-31	-29.09%
2017-12-31	-38.30%
2017-09-30	-55.85%
2017-06-30	-63.68%
2017-03-31	-80.99%
2016-12-31	-44.81%
2016-09-30	-35.76%
2016-06-30	-32.36%
2016-03-31	-25.91%
2015-12-31	-20.95%
2015-09-30	-17.69%
2015-06-30	-12.96%
2015-03-31	-10.29%
2014-12-31	-29.01%
2014-09-30	-23.09%
2014-06-30	-19.84%
2014-03-31	-18.56%
2013-12-31	-38.28%
2013-09-30	-20.08%
2013-06-30	-13.16%
2013-03-31	-4.25%
2012-12-31	3.26%
2012-09-30	-2.19%
2012-06-30	21.64%
2012-03-31	23.50%
2011-12-31	62.53%
2011-09-30	67.06%
2011-06-30	41.78%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	14.74%
2024-12-31	13.21%
2023-12-31	11.22%
2022-12-31	9.08%
2021-12-31	6.52%
2020-12-31	36.17%
2019-12-31	5.81%
2018-12-31	4.39%
2017-12-31	-38.30%
2016-12-31	-44.81%
2015-12-31	-20.95%
2014-12-31	-29.01%
2013-12-31	-38.28%
2012-12-31	3.26%
2011-12-31	62.53%
2010-12-31	-41.19%
2009-12-31	-1290.79%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
EXELIXIS, INC. (EXEL)	United States	$14.358B	16.15
HALOZYME THERAPEUTICS, INC. (HALO)	United States	$13.083B	21.59
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Krystal Biotech, Inc. (KRYS)	United States	$10.210B	45.56
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29
Vaxcyte, Inc. (PCVX)	United States	$8.466B	-7.91
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78